Commentary: Benefits of SGLT2 inhibition in heart failure: A bellwether for importance of other metabolic pathways.

Authors :: Ferraris VA
Source :: The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2022 Sep; Vol. 164 (3), pp. 900-901. Date of Electronic Publication: 2021 Mar 27.
Publication Year :: 2022

Subjects :: Humans
Metabolic Networks and Pathways
Sodium-Glucose Transporter 2 metabolism
Diabetes Mellitus, Type 2
Heart Failure drug therapy
Heart Failure metabolism
Sodium-Glucose Transporter 2 Inhibitors therapeutic use

Full Text Access

Tools